antihemophilic factor (human) + von willebrand factor (human)

antihemophilic factor (human) + von willebrand factor (human) is a plasma-derived coagulation factor replacement product marketed as Wilate by Octapharma. It contains human von Willebrand factor and coagulation factor VIII purified from human plasma and is administered intravenously to replace deficient or dysfunctional VWF and associated FVIII, thereby restoring primary hemostasis and supporting coagulation. The product is approved for von Willebrand disease for on-demand bleed control, perioperative management, and routine prophylaxis, and for hemophilia A for on-demand treatment and routine prophylaxis.

Brand names

Wilate

Other names

antihemophilic factor (human) + von willebrand factor (human)coagulation factor viii + von willebrand factor complex (human)factor viii/von willebrand factor complex (human)